| Current Price | $8.12 | Mkt Cap | $275.7M |
|---|---|---|---|
| Open | $8.17 | P/E Ratio | 0.00 |
| Prev. Close | $8.12 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $7.95 - $8.18 | Volume | 147,385 |
| 52-Wk Range | $7.57 - $13.49 | Avg. Daily Vol. | 175,474 |
| Current Price | $8.12 | Mkt Cap | $275.7M |
|---|---|---|---|
| Open | $8.17 | P/E Ratio | 0.00 |
| Prev. Close | $8.12 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $7.95 - $8.18 | Volume | 147,385 |
| 52-Wk Range | $7.57 - $13.49 | Avg. Daily Vol. | 175,474 |
The best Bull and Bear pitches based on recency and number of recommendations.
With market expectations now at rock-bottom thanks to Friday's press release, I believe now is a good time to initiate a position in Celladon.
Read the most recent pitches from players about EIGR.
Recs
oscillation
(75.32)
Submitted: 5/28/2015 9:24:56 AM :
Start Price:
$32.40
NASDAQ:EIGR Score:
-182.13
nev
Recs
treasureoaks
(22.66)
Submitted: 4/22/2015 3:54:19 PM :
Start Price:
$203.85
NASDAQ:EIGR Score:
-204.89
Oversold.
Recs
Jimbyrnes1969
(< 20)
Submitted: 4/9/2015 1:25:22 PM :
Start Price:
$252.36
NASDAQ:EIGR Score:
-208.03
I believe the Mydicar therapy is revolutionary and will help to boost Celladon's stock price much higher in relation to the market over the next 2-4 years. The Cupid2 study results being released later this month- if positive, will propel the stock 300% in the short term but the real value will be when the therapy hits the market.
Find the members with the highest scoring picks in EIGR.
GreenAB (27.93) Score: +207.54
The Score Leader is the player with the highest score across all their picks in EIGR.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| GreenAB | 27.93 | 3/20/2015 |
|
NS | $405.00 | -98.00% | +109.54% | +207.54 | 0 Comment | |
| IdahoInvestor | 27.27 | 8/17/2015 |
|
5Y | $15.75 | -48.44% | +110.79% | +159.23 | 0 Comment | |
| jon5555 | 91.47 | 9/29/2020 |
|
5Y | $8.29 | -2.05% | +32.03% | +34.08 | 0 Comment | |
|
OneBee | 31.17 | 5/4/2021 |
|
3M | $8.67 | -6.34% | +5.72% | -12.07 | 0 Comment |
| sikiliza | < 20 | 3/13/2020 |
|
5Y | $5.71 | +42.21% | +67.14% | -24.94 | 0 Comment | |
| foggs1 | 66.99 | 3/17/2021 |
|
5Y | $10.12 | -19.76% | +11.51% | -31.27 | 0 Comment | |
| odocoileus | 57.74 | 9/10/2020 |
|
5Y | $10.48 | -22.52% | +31.35% | -53.87 | 0 Comment | |
| drugtrader | 86.15 | 7/8/2020 |
|
5Y | $9.43 | -13.89% | +40.62% | -54.51 | 0 Comment | |
| Playa14 | < 20 | 1/16/2018 |
|
5Y | $8.48 | -4.23% | +58.07% | -62.30 | 0 Comment | |
| BigDreamer | 57.35 | 1/29/2018 |
|
3Y | $8.95 | -9.27% | +53.86% | -63.14 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
